Browsing by Issue Date, starting with "2019-09-12"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Effects of industrial boiling on the nutritional profile of common octopus (Octopus vulgaris)Publication . Oliveira, Helena; Muniz, José António; Bandarra, Narcisa Maria; Castanheira, Isabel; Coelho, Inês Ribeiro; Delgado, Inês; Gonçalves, Susana; Lourenço, Helena Maria; Motta, Carla; Duarte, Maria Paula; Nunes, Maria Leonor; Gonçalves, AmparoIndustrial cooking of common octopus (Octopus vulgaris) under well-established procedures is advantageous for current consumers, which demand healthy and convenient food. This work aimed to evaluate the e ect of industrial water boiling, without the addition of salt, on the nutritional profile of common octopus. True retentions (TRs) were calculated for essential nutrients and toxic elements. After boiling, the moisture content decreased, resulting in a concentration of other constituents (protein, fat, fatty acids, majority of amino acids, phosphorus, zinc, and iodine). High TRs were obtained for some essential nutrients: 90.2% (eicosapentaenoic acid, EPA), 89.1% (docosahexaenoic acid, DHA), 74.6% (indispensable amino acids, IAA), and 86.8% (iodine). In both raw and boiled octopus, polyunsaturated fatty acids (252.2 and 425.1 mg/100 g), leucine (940.1 and 1613.4 mg/100 g), glutamate (1971.5 and 3257.1 mg/100 g), sodium (393.3 and 332.5 mg/100 g), and zinc (12.6 and 16.6 mg/kg) were, respectively, the most abundant fatty acids, IAA, dispensable amino acids, macro, and micro elements. Cadmium, lead, and mercury levels found in boiled octopus were 0.02, 0.10, and 0.08 mg/kg, respectively. The consumption of 150 g (usual portion) of boiled octopus is advisable because it contributes to significant daily intakes of EPA+DHA (>100%), selenium (75.6%), and iodine (12.4%), and 25% of the daily adequate intake of sodium for adults.
- The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st centuryPublication . Caini, Saverio; Kusznierz, Gabriela; Garate, Verònica Vera; Wangchuk, Sonam; Thapa, Binay; de Paula Júnior, Francisco José; Ferreira de Almeida, Walquiria Aparecida; Njouom, Richard; Fasce, Rodrigo A.; Bustos, Patricia; Feng, Luzhao; Peng, Zhibin; Araya, Jenny Lara; Bruno, Alfredo; de Mora, Doménica; Barahona de Gámez, Mónica Jeannette; Pebody, Richard; Zambon, Maria; Higueros, Rocio; Rivera, Rudevelinda; Kosasih, Herman; Castrucci, Maria Rita; Bella, Antonino; Kadjo, Hervé A.; Daouda, Coulibaly; Makusheva, Ainash; Bessonova, Olga; Chaves, Sandra S.; Emukule, Gideon O.; Heraud, Jean-Michel; Razanajatovo, Norosoa H.; Barakat, Amal; El Falaki, Fatima; Meijer, Adam; Donker, Gé A.; Huang, Q. Sue; Wood, Tim; Balmaseda, Angel; Palekar, Rakhee; Arévalo, Brechla Moreno; Rodrigues, Ana Paula; Guiomar, Raquel; Lee, Vernon Jian Ming; Ang, Li Wei; Cohen, Cheryl; Treurnicht, Florette; Mironenko, Alla; Holubka, Olha; Bresee, Joseph; Brammer, Lynnette; Le, Mai T.Q.; Hoang, Phuong V.M.; El Guerche-Séblain, Clotilde; Paget, John; Global Influenza B Study teamWe describe the epidemiological characteristics, pattern of circulation, and geographical distribution of influenza B viruses and its lineages using data from the Global Influenza B Study. We included over 1.8 million influenza cases occurred in thirty-one countries during 2000-2018. We calculated the proportion of cases caused by influenza B and its lineages; determined the timing of influenza A and B epidemics; compared the age distribution of B/Victoria and B/Yamagata cases; and evaluated the frequency of lineage-level mismatch for the trivalent vaccine. The median proportion of influenza cases caused by influenza B virus was 23.4%, with a tendency (borderline statistical significance, p = 0.060) to be higher in tropical vs. temperate countries. Influenza B was the dominant virus type in about one every seven seasons. In temperate countries, influenza B epidemics occurred on average three weeks later than influenza A epidemics; no consistent pattern emerged in the tropics. The two B lineages caused a comparable proportion of influenza B cases globally, however the B/Yamagata was more frequent in temperate countries, and the B/Victoria in the tropics (p = 0.048). B/Yamagata patients were significantly older than B/Victoria patients in almost all countries. A lineage-level vaccine mismatch was observed in over 40% of seasons in temperate countries and in 30% of seasons in the tropics. The type B virus caused a substantial proportion of influenza infections globally in the 21st century, and its two virus lineages differed in terms of age and geographical distribution of patients. These findings will help inform health policy decisions aiming to reduce disease burden associated with seasonal influenza.